Last edition
News about "Turn Biotechnologies"
HanAll Biopharma and Turn Bio to Develop Novel Treatments for Eye and Ear Diseases
HanAll Biopharma Co., Ltd. has signed an exclusive licensing deal with Turn Biotechnologies, Inc., a pre-clinical stage biopharmaceutical company focused on cellular repair through epigenetic reprogramming.
Turn Biotechnologies | 29/05/2024 | By Aishwarya | 1190
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members